Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Anti-idiotypic
Patent
1985-09-03
1987-04-14
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Anti-idiotypic
514495, A61K 3128, A61K 3324
Patent
active
046577637
ABSTRACT:
Lysosomal enzymes and superoxide radicals (O.sub.2.sup.-) are potent mediators of rheumatoid inflammation. It is known that gold sodium thiosulphate (GTS), an injectable gold compound, inhibits lysosomal enzymes activity without however affecting its release, whereas auranofin (AF), an oral gold compound, inhibits such release but not enzyme activity. And while AF inhibits the generation of O.sub.2.sup.-, GTS is without significant effect. It has been discovered, using O.sub.2.sup.- production as an indicator of respiratory burst, that subtherapeutic concentrations of the oral gold having only partial inhibitory activity on O.sub.2.sup.- production, give rise to greatly enhanced inhibitory activity in such production when the oral gold is functionally combined with the otherwise inactive injectable gold. The effect of this combination of drugs is synergistic in that it far exceeds the sum of the individual inhibitory activities of the oral and injectable gold compounds. A further increase in O.sub.2.sup.- production inhibition is realized by adding to the combination of gold compounds hydroxychoroquine, an anti-malarial agent.
REFERENCES:
Chem. Abst. 95 (1981) 194766j.
Chem. Abst. 99 (1983) 128198g.
Ebert Michael
Ebert Michael
Friedman Stanley J.
LandOfFree
Combined chrysotherapeutic agents for autoimmune diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combined chrysotherapeutic agents for autoimmune diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combined chrysotherapeutic agents for autoimmune diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1784525